Status:
COMPLETED
The Importance of Ghrelin for Glucose Metabolism After Sleeve Gastrectomy
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Institute of Biomedical Sciences, SUND, University of Copenhagen
Conditions:
Bariatric Surgery Candidate
Glucose Metabolism Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall aim is to delineate the contribution of ghrelin to glucose tolerance after sleeve gastrectomy. The hypothesis is that decreased concentration of ghrelin after SG is of importance for impro...
Detailed Description
Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are bariatric procedures. Overwhelming evidence support bariatric surgery as the most effective treatment for severe obesity and related met...
Eligibility Criteria
Inclusion
- Sleeve gastrectomy-operated \> 12 months prior to inclusion
- Weight stable (+/- 3 kg during the last 3 months)
- Fasting glucose \< 7,0 mmol/l / HbA1c \< 48 mmol/mol pre- and postoperative
- Signed written informed consent
Exclusion
- Pregnancy or breastfeeding.
- Haemoglobin \< 6,5 mM.
Key Trial Info
Start Date :
January 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 26 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT05189353
Start Date
January 14 2022
End Date
June 26 2023
Last Update
November 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre Universitets Hospital
Hvidovre, Denmark, 2650